| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| CVS - CVS Health Corp | HOLD | 0 @ USD 63.94 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 63.94. The average price that CVS shares were previous bought at was USD 63.5284. The current market price is 0.6% higher than average price they were purchased at. The value of the holding in CVS has fallen by USD 244,135 compared to the previous valuation of CVS Health Corp |
| DVA - DaVita HealthCare Partners Inc | SELL | -92 @ USD 140.53 | USD -12,929 | The ETF sold 92 shares of DVA on 2025-07-15. The shares were previously bought for an average price of USD 152.044. The DaVita HealthCare Partners Inc shares were sold for -7.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,059 The average price that the ETF previously sold DVA share for is USD 147.764 which is higher than the selling price of USD 140.53 on 2025-07-15. |
| CRL - Creightons Plc | SELL | -108 @ USD 154.42 | USD -16,677 | The ETF sold 108 shares of CRL on 2025-07-15. The shares were previously bought for an average price of USD 166.023. The Creightons Plc shares were sold for -7.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,253 The average price that the ETF previously sold CRL share for is USD 174.763 which is higher than the selling price of USD 154.42 on 2025-07-15. |
| TECH - Bio-Techne Corp | SELL | -344 @ USD 51.42 | USD -17,688 | The ETF sold 344 shares of TECH on 2025-07-15. The shares were previously bought for an average price of USD 62.9582. The Bio-Techne Corp shares were sold for -18.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,969 The average price that the ETF previously sold TECH share for is USD 66.6317 which is higher than the selling price of USD 51.42 on 2025-07-15. |
| HSIC - Henry Schein Inc | SELL | -276 @ USD 70.64 | USD -19,497 | The ETF sold 276 shares of HSIC on 2025-07-15. The shares were previously bought for an average price of USD 72.5313. The Henry Schein Inc shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of USD 522 The average price that the ETF previously sold HSIC share for is USD 71.2555 which is higher than the selling price of USD 70.64 on 2025-07-15. |
| UHS - Universal Health Services Inc | SELL | -124 @ USD 176.94 | USD -21,941 | The ETF sold 124 shares of UHS on 2025-07-15. The shares were previously bought for an average price of USD 186.901. The Universal Health Services Inc shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,235 The average price that the ETF previously sold UHS share for is USD 189.895 which is higher than the selling price of USD 176.94 on 2025-07-15. |
| SOLV - Solventum Corp. | SELL | -308 @ USD 73.68 | USD -22,693 | The ETF sold 308 shares of SOLV on 2025-07-15. The shares were previously bought for an average price of USD 73.9165. The Solventum Corp. shares were sold for -0.3% lower than average price of previous purchases. This resulted in an overall loss of USD 73 The average price that the ETF previously sold SOLV share for is USD 71.0973 so the ETF has sold 308 shares on 2025-07-15 at a higher price than the previous selling average. |
| MRNA - Moderna Inc | SELL | -736 @ USD 31.58 | USD -23,243 | The ETF sold 736 shares of MRNA on 2025-07-15. The shares were previously bought for an average price of USD 34.1169. The Moderna Inc shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,867 The average price that the ETF previously sold MRNA share for is USD 38.9739 which is higher than the selling price of USD 31.58 on 2025-07-15. |
| VTRS - Viatris Inc | SELL | -2,668 @ USD 8.93 | USD -23,825 | The ETF sold 2668 shares of VTRS on 2025-07-15. The shares were previously bought for an average price of USD 10.2249. The Viatris Inc shares were sold for -12.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,455 The average price that the ETF previously sold VTRS share for is USD 11.4735 which is higher than the selling price of USD 8.93 on 2025-07-15. |
| INCY - Incyte Corporation | SELL | -356 @ USD 68.25 | USD -24,297 | The ETF sold 356 shares of INCY on 2025-07-15. The shares were previously bought for an average price of USD 68.9686. The Incyte Corporation shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of USD 256 The average price that the ETF previously sold INCY share for is USD 71.7191 which is higher than the selling price of USD 68.25 on 2025-07-15. |
| RVTY - Revvity Inc. | SELL | -260 @ USD 95.9 | USD -24,934 | The ETF sold 260 shares of RVTY on 2025-07-15. The shares were previously bought for an average price of USD 110.032. The Revvity Inc. shares were sold for -12.8% lower than average price of previous purchases. This resulted in an overall loss of USD 3,674 The average price that the ETF previously sold RVTY share for is USD 108.962 which is higher than the selling price of USD 95.9 on 2025-07-15. |
| MOH - MOH | SELL | -120 @ USD 214.61 | USD -25,753 | The ETF sold 120 shares of MOH on 2025-07-15. The shares were previously bought for an average price of USD 306.545. The MOH shares were sold for -30.0% lower than average price of previous purchases. This resulted in an overall loss of USD 11,032 The average price that the ETF previously sold MOH share for is USD 301.472 which is higher than the selling price of USD 214.61 on 2025-07-15. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -120 @ USD 214.61 | USD -25,753 | The ETF sold 120 shares of MOH on 2025-07-15. The shares were previously bought for an average price of USD 306.545. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -30.0% lower than average price of previous purchases. This resulted in an overall loss of USD 11,032 The average price that the ETF previously sold MOH share for is USD 301.472 which is higher than the selling price of USD 214.61 on 2025-07-15. |
| ALGN - Align Technology Inc | SELL | -148 @ USD 192.81 | USD -28,536 | The ETF sold 148 shares of ALGN on 2025-07-15. The shares were previously bought for an average price of USD 187.06. The Align Technology Inc shares were sold for 3.1% higher than average price of previous purchases. This sale made a profit of USD 851 The average price that the ETF previously sold ALGN share for is USD 206.205 which is higher than the selling price of USD 192.81 on 2025-07-15. |
| HOLX - Hologic Inc | SELL | -492 @ USD 63.26 | USD -31,124 | The ETF sold 492 shares of HOLX on 2025-07-15. The shares were previously bought for an average price of USD 66.5861. The Hologic Inc shares were sold for -5.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,636 The average price that the ETF previously sold HOLX share for is USD 70.7317 which is higher than the selling price of USD 63.26 on 2025-07-15. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -444 @ USD 72.2 | USD -32,057 | The ETF sold 444 shares of COO on 2025-07-15. The shares were previously bought for an average price of USD 86.8441. The The Cooper Companies, Inc. Common Stock shares were sold for -16.9% lower than average price of previous purchases. This resulted in an overall loss of USD 6,502 The average price that the ETF previously sold COO share for is USD 91.2418 which is higher than the selling price of USD 72.2 on 2025-07-15. |
| BAX - Baxter International Inc | SELL | -1,148 @ USD 28.25 | USD -32,431 | The ETF sold 1148 shares of BAX on 2025-07-15. The shares were previously bought for an average price of USD 32.4244. The Baxter International Inc shares were sold for -12.9% lower than average price of previous purchases. This resulted in an overall loss of USD 4,792 The average price that the ETF previously sold BAX share for is USD 31.9819 which is higher than the selling price of USD 28.25 on 2025-07-15. |
| CNC - Concurrent Technologies Plc | SELL | -1,104 @ USD 30 | USD -33,120 | The ETF sold 1104 shares of CNC on 2025-07-15. The shares were previously bought for an average price of USD 59.2099. The Concurrent Technologies Plc shares were sold for -49.3% lower than average price of previous purchases. This resulted in an overall loss of USD 32,248 The average price that the ETF previously sold CNC share for is USD 58.0442 which is higher than the selling price of USD 30 on 2025-07-15. |
| WST - West Pharmaceutical Services Inc | SELL | -156 @ USD 221.05 | USD -34,484 | The ETF sold 156 shares of WST on 2025-07-15. The shares were previously bought for an average price of USD 251.218. The West Pharmaceutical Services Inc shares were sold for -12.0% lower than average price of previous purchases. This resulted in an overall loss of USD 4,706 The average price that the ETF previously sold WST share for is USD 287.879 which is higher than the selling price of USD 221.05 on 2025-07-15. |
| WAT - Waters Corporation | SELL | -128 @ USD 289.56 | USD -37,064 | The ETF sold 128 shares of WAT on 2025-07-15. The shares were previously bought for an average price of USD 362.82. The Waters Corporation shares were sold for -20.2% lower than average price of previous purchases. This resulted in an overall loss of USD 9,377 The average price that the ETF previously sold WAT share for is USD 365.606 which is higher than the selling price of USD 289.56 on 2025-07-15. |
| WAT - MULETFWATIMETFP | SELL | -128 @ USD 289.56 | USD -37,064 | The ETF sold 128 shares of WAT on 2025-07-15. The shares were previously bought for an average price of USD 362.82. The MULETFWATIMETFP shares were sold for -20.2% lower than average price of previous purchases. This resulted in an overall loss of USD 9,377 The average price that the ETF previously sold WAT share for is USD 365.606 which is higher than the selling price of USD 289.56 on 2025-07-15. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -436 @ USD 94.03 | USD -40,997 | The ETF sold 436 shares of ZBH on 2025-07-15. The shares were previously bought for an average price of USD 104.881. The Zimmer Biomet Holdings Inc shares were sold for -10.3% lower than average price of previous purchases. This resulted in an overall loss of USD 4,731 The average price that the ETF previously sold ZBH share for is USD 104.673 which is higher than the selling price of USD 94.03 on 2025-07-15. |
| DGX - Quest Diagnostics Incorporated | SELL | -248 @ USD 166.42 | USD -41,272 | The ETF sold 248 shares of DGX on 2025-07-15. The shares were previously bought for an average price of USD 168.441. The Quest Diagnostics Incorporated shares were sold for -1.2% lower than average price of previous purchases. This resulted in an overall loss of USD 501 The average price that the ETF previously sold DGX share for is USD 163.029 so the ETF has sold 248 shares on 2025-07-15 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -324 @ USD 127.5 | USD -41,310 | The ETF sold 324 shares of BIIB on 2025-07-15. The shares were previously bought for an average price of USD 141.02. The Biogen Inc shares were sold for -9.6% lower than average price of previous purchases. This resulted in an overall loss of USD 4,380 The average price that the ETF previously sold BIIB share for is USD 152.13 which is higher than the selling price of USD 127.5 on 2025-07-15. |
| PODD - Insulet Corporation | SELL | -152 @ USD 289.99 | USD -44,078 | The ETF sold 152 shares of PODD on 2025-07-15. The shares were previously bought for an average price of USD 277.376. The Insulet Corporation shares were sold for 4.5% higher than average price of previous purchases. This sale made a profit of USD 1,917 The average price that the ETF previously sold PODD share for is USD 270.974 so the ETF has sold 152 shares on 2025-07-15 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -184 @ USD 245.65 | USD -45,200 | The ETF sold 184 shares of LH on 2025-07-15. The shares were previously bought for an average price of USD 246.13. The Laboratory Corporation of America Holdings shares were sold for -0.2% lower than average price of previous purchases. This resulted in an overall loss of USD 88 The average price that the ETF previously sold LH share for is USD 240.108 so the ETF has sold 184 shares on 2025-07-15 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -216 @ USD 228.84 | USD -49,429 | The ETF sold 216 shares of STE on 2025-07-15. The shares were previously bought for an average price of USD 223.954. The STERIS plc shares were sold for 2.2% higher than average price of previous purchases. This sale made a profit of USD 1,055 The average price that the ETF previously sold STE share for is USD 219.868 so the ETF has sold 216 shares on 2025-07-15 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -44 @ USD 1168.56 | USD -51,417 | The ETF sold 44 shares of MTD on 2025-07-15. The shares were previously bought for an average price of USD 1228.19. The Mettler-Toledo International Inc shares were sold for -4.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,624 The average price that the ETF previously sold MTD share for is USD 1227.97 which is higher than the selling price of USD 1168.56 on 2025-07-15. |
| MTD - AMUNDI EUR GOV 710 | SELL | -44 @ USD 1168.56 | USD -51,417 | The ETF sold 44 shares of MTD on 2025-07-15. The shares were previously bought for an average price of USD 1228.19. The AMUNDI EUR GOV 710 shares were sold for -4.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,624 The average price that the ETF previously sold MTD share for is USD 1227.97 which is higher than the selling price of USD 1168.56 on 2025-07-15. |
| IQV - IQVIA Holdings Inc | SELL | -360 @ USD 157.68 | USD -56,765 | The ETF sold 360 shares of IQV on 2025-07-15. The shares were previously bought for an average price of USD 186.439. The IQVIA Holdings Inc shares were sold for -15.4% lower than average price of previous purchases. This resulted in an overall loss of USD 10,353 The average price that the ETF previously sold IQV share for is USD 188.041 which is higher than the selling price of USD 157.68 on 2025-07-15. |
| HUM - Hummingbird Resources PLC | SELL | -268 @ USD 221.9 | USD -59,469 | The ETF sold 268 shares of HUM on 2025-07-15. The shares were previously bought for an average price of USD 263.605. The Hummingbird Resources PLC shares were sold for -15.8% lower than average price of previous purchases. This resulted in an overall loss of USD 11,177 The average price that the ETF previously sold HUM share for is USD 268.921 which is higher than the selling price of USD 221.9 on 2025-07-15. |
| HUM - Humana Inc | SELL | -268 @ USD 221.9 | USD -59,469 | The ETF sold 268 shares of HUM on 2025-07-15. The shares were previously bought for an average price of USD 263.605. The Humana Inc shares were sold for -15.8% lower than average price of previous purchases. This resulted in an overall loss of USD 11,177 The average price that the ETF previously sold HUM share for is USD 268.921 which is higher than the selling price of USD 221.9 on 2025-07-15. |
| A - Agilent Technologies Inc | SELL | -636 @ USD 112.94 | USD -71,830 | The ETF sold 636 shares of A on 2025-07-15. The shares were previously bought for an average price of USD 126.417. The Agilent Technologies Inc shares were sold for -10.7% lower than average price of previous purchases. This resulted in an overall loss of USD 8,571 The average price that the ETF previously sold A share for is USD 129.772 which is higher than the selling price of USD 112.94 on 2025-07-15. |
| DXCM - DexCom Inc | SELL | -868 @ USD 84.78 | USD -73,589 | The ETF sold 868 shares of DXCM on 2025-07-15. The shares were previously bought for an average price of USD 78.3581. The DexCom Inc shares were sold for 8.2% higher than average price of previous purchases. This sale made a profit of USD 5,574 The average price that the ETF previously sold DXCM share for is USD 77.4504 so the ETF has sold 868 shares on 2025-07-15 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -1,020 @ USD 74.39 | USD -75,878 | The ETF sold 1020 shares of GEHC on 2025-07-15. The shares were previously bought for an average price of USD 82.0681. The GE HealthCare Technologies Inc. shares were sold for -9.4% lower than average price of previous purchases. This resulted in an overall loss of USD 7,832 The average price that the ETF previously sold GEHC share for is USD 79.5165 which is higher than the selling price of USD 74.39 on 2025-07-15. |
| RMD - ResMed Inc | SELL | -324 @ USD 252.01 | USD -81,651 | The ETF sold 324 shares of RMD on 2025-07-15. The shares were previously bought for an average price of USD 237.406. The ResMed Inc shares were sold for 6.2% higher than average price of previous purchases. This sale made a profit of USD 4,732 The average price that the ETF previously sold RMD share for is USD 242.776 so the ETF has sold 324 shares on 2025-07-15 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -528 @ USD 161.02 | USD -85,019 | The ETF sold 528 shares of CAH on 2025-07-15. The shares were previously bought for an average price of USD 132.76. The Cardinal Health Inc shares were sold for 21.3% higher than average price of previous purchases. This sale made a profit of USD 14,921 The average price that the ETF previously sold CAH share for is USD 131.492 so the ETF has sold 528 shares on 2025-07-15 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -176 @ USD 526.66 | USD -92,692 | The ETF sold 176 shares of IDXX on 2025-07-15. The shares were previously bought for an average price of USD 451.69. The IDEXX Laboratories Inc shares were sold for 16.6% higher than average price of previous purchases. This sale made a profit of USD 13,195 The average price that the ETF previously sold IDXX share for is USD 447.526 so the ETF has sold 176 shares on 2025-07-15 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -1,304 @ USD 76.81 | USD -100,160 | The ETF sold 1304 shares of EW on 2025-07-15. The shares were previously bought for an average price of USD 71.5785. The Edwards Lifesciences Corp shares were sold for 7.3% higher than average price of previous purchases. This sale made a profit of USD 6,822 The average price that the ETF previously sold EW share for is USD 71.4678 so the ETF has sold 1304 shares on 2025-07-15 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -380 @ USD 294.65 | USD -111,967 | The ETF sold 380 shares of COR on 2025-07-15. The shares were previously bought for an average price of USD 261.802. The Cencora Inc. shares were sold for 12.5% higher than average price of previous purchases. This sale made a profit of USD 12,482 The average price that the ETF previously sold COR share for is USD 255.701 so the ETF has sold 380 shares on 2025-07-15 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -636 @ USD 178.31 | USD -113,405 | The ETF sold 636 shares of BDX on 2025-07-15. The shares were previously bought for an average price of USD 219.065. The Becton Dickinson and Company shares were sold for -18.6% lower than average price of previous purchases. This resulted in an overall loss of USD 25,920 The average price that the ETF previously sold BDX share for is USD 213.181 which is higher than the selling price of USD 178.31 on 2025-07-15. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -232 @ USD 547.96 | USD -127,127 | The ETF sold 232 shares of REGN on 2025-07-15. The shares were previously bought for an average price of USD 679.66. The Regeneron Pharmaceuticals Inc shares were sold for -19.4% lower than average price of previous purchases. This resulted in an overall loss of USD 30,554 The average price that the ETF previously sold REGN share for is USD 701.362 which is higher than the selling price of USD 547.96 on 2025-07-15. |
| HCA - HCA Holdings Inc | SELL | -384 @ USD 371.8 | USD -142,771 | The ETF sold 384 shares of HCA on 2025-07-15. The shares were previously bought for an average price of USD 342.952. The HCA Holdings Inc shares were sold for 8.4% higher than average price of previous purchases. This sale made a profit of USD 11,078 The average price that the ETF previously sold HCA share for is USD 339.468 so the ETF has sold 384 shares on 2025-07-15 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -984 @ USD 152.86 | USD -150,414 | The ETF sold 984 shares of ZTS on 2025-07-15. The shares were previously bought for an average price of USD 166.363. The Zoetis Inc shares were sold for -8.1% lower than average price of previous purchases. This resulted in an overall loss of USD 13,287 The average price that the ETF previously sold ZTS share for is USD 168.983 which is higher than the selling price of USD 152.86 on 2025-07-15. |
| ELV - Elevance Health Inc | SELL | -500 @ USD 336.21 | USD -168,105 | The ETF sold 500 shares of ELV on 2025-07-15. The shares were previously bought for an average price of USD 405.601. The Elevance Health Inc shares were sold for -17.1% lower than average price of previous purchases. This resulted in an overall loss of USD 34,696 The average price that the ETF previously sold ELV share for is USD 394.166 which is higher than the selling price of USD 336.21 on 2025-07-15. |
| ELV - Elevance Health Inc | SELL | -500 @ USD 336.21 | USD -168,105 | The ETF sold 500 shares of ELV on 2025-07-15. The shares were previously bought for an average price of USD 405.601. The Elevance Health Inc shares were sold for -17.1% lower than average price of previous purchases. This resulted in an overall loss of USD 34,696 The average price that the ETF previously sold ELV share for is USD 394.166 which is higher than the selling price of USD 336.21 on 2025-07-15. |
| CI - Cigna Corp | SELL | -592 @ USD 302.44 | USD -179,044 | The ETF sold 592 shares of CI on 2025-07-15. The shares were previously bought for an average price of USD 316.282. The Cigna Corp shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of USD 8,194 The average price that the ETF previously sold CI share for is USD 312.867 which is higher than the selling price of USD 302.44 on 2025-07-15. |
| MCK - McKesson Corporation | SELL | -276 @ USD 710.82 | USD -196,186 | The ETF sold 276 shares of MCK on 2025-07-15. The shares were previously bought for an average price of USD 639.059. The McKesson Corporation shares were sold for 11.2% higher than average price of previous purchases. This sale made a profit of USD 19,806 The average price that the ETF previously sold MCK share for is USD 623.442 so the ETF has sold 276 shares on 2025-07-15 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -4,532 @ USD 46.43 | USD -210,421 | The ETF sold 4532 shares of BMY on 2025-07-15. The shares were previously bought for an average price of USD 55.4006. The Bloomsbury Publishing Plc shares were sold for -16.2% lower than average price of previous purchases. This resulted in an overall loss of USD 40,655 The average price that the ETF previously sold BMY share for is USD 54.6609 which is higher than the selling price of USD 46.43 on 2025-07-15. |
| MDT - Medtronic PLC | SELL | -2,856 @ USD 89.22 | USD -254,812 | The ETF sold 2856 shares of MDT on 2025-07-15. The shares were previously bought for an average price of USD 88.3291. The Medtronic PLC shares were sold for 1.0% higher than average price of previous purchases. This sale made a profit of USD 2,544 The average price that the ETF previously sold MDT share for is USD 85.7728 so the ETF has sold 2856 shares on 2025-07-15 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -568 @ USD 464.2 | USD -263,666 | The ETF sold 568 shares of VRTX on 2025-07-15. The shares were previously bought for an average price of USD 472.108. The Vertex Pharmaceuticals Inc shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 4,492 The average price that the ETF previously sold VRTX share for is USD 462.092 so the ETF has sold 568 shares on 2025-07-15 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -1,416 @ USD 192.86 | USD -273,090 | The ETF sold 1416 shares of DHR on 2025-07-15. The shares were previously bought for an average price of USD 213.818. The Danaher Corporation shares were sold for -9.8% lower than average price of previous purchases. This resulted in an overall loss of USD 29,677 The average price that the ETF previously sold DHR share for is USD 224.595 which is higher than the selling price of USD 192.86 on 2025-07-15. |
| DHR - Danaher Corporation | SELL | -1,416 @ USD 192.86 | USD -273,090 | The ETF sold 1416 shares of DHR on 2025-07-15. The shares were previously bought for an average price of USD 213.818. The Danaher Corporation shares were sold for -9.8% lower than average price of previous purchases. This resulted in an overall loss of USD 29,677 The average price that the ETF previously sold DHR share for is USD 224.595 which is higher than the selling price of USD 192.86 on 2025-07-15. |
| SYK - Stryker Corporation | SELL | -764 @ USD 390.59 | USD -298,411 | The ETF sold 764 shares of SYK on 2025-07-15. The shares were previously bought for an average price of USD 378.931. The Stryker Corporation shares were sold for 3.1% higher than average price of previous purchases. This sale made a profit of USD 8,907 The average price that the ETF previously sold SYK share for is USD 377.328 so the ETF has sold 764 shares on 2025-07-15 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -2,768 @ USD 109.06 | USD -301,878 | The ETF sold 2768 shares of GILD on 2025-07-15. The shares were previously bought for an average price of USD 103.816. The Guild Esports Plc shares were sold for 5.1% higher than average price of previous purchases. This sale made a profit of USD 14,515 The average price that the ETF previously sold GILD share for is USD 97.4475 so the ETF has sold 2768 shares on 2025-07-15 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -12,660 @ USD 24.61 | USD -311,563 | The ETF sold 12660 shares of PFE on 2025-07-15. The shares were previously bought for an average price of USD 25.4721. The Pfizer Inc shares were sold for -3.4% lower than average price of previous purchases. This resulted in an overall loss of USD 10,914 The average price that the ETF previously sold PFE share for is USD 25.638 which is higher than the selling price of USD 24.61 on 2025-07-15. |
| BSX - Boston Scientific Corporation | SELL | -3,292 @ USD 103.48 | USD -340,656 | The ETF sold 3292 shares of BSX on 2025-07-15. The shares were previously bought for an average price of USD 99.2677. The Boston Scientific Corporation shares were sold for 4.2% higher than average price of previous purchases. This sale made a profit of USD 13,867 The average price that the ETF previously sold BSX share for is USD 93.1328 so the ETF has sold 3292 shares on 2025-07-15 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -3,292 @ USD 103.48 | USD -340,656 | The ETF sold 3292 shares of BSX on 2025-07-15. The shares were previously bought for an average price of USD 99.2677. The MULSTRXSSXIMETFP shares were sold for 4.2% higher than average price of previous purchases. This sale made a profit of USD 13,867 The average price that the ETF previously sold BSX share for is USD 93.1328 so the ETF has sold 3292 shares on 2025-07-15 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -1,192 @ USD 292.51 | USD -348,672 | The ETF sold 1192 shares of AMGN on 2025-07-15. The shares were previously bought for an average price of USD 300.759. The Amgen Inc shares were sold for -2.7% lower than average price of previous purchases. This resulted in an overall loss of USD 9,833 The average price that the ETF previously sold AMGN share for is USD 288.491 so the ETF has sold 1192 shares on 2025-07-15 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -840 @ USD 417.99 | USD -351,112 | The ETF sold 840 shares of TMO on 2025-07-15. The shares were previously bought for an average price of USD 504.88. The Time Out Group plc shares were sold for -17.2% lower than average price of previous purchases. This resulted in an overall loss of USD 72,988 The average price that the ETF previously sold TMO share for is USD 496.551 which is higher than the selling price of USD 417.99 on 2025-07-15. |
| ISRG - Intuitive Surgical Inc | SELL | -796 @ USD 512.23 | USD -407,735 | The ETF sold 796 shares of ISRG on 2025-07-15. The shares were previously bought for an average price of USD 535.412. The Intuitive Surgical Inc shares were sold for -4.3% lower than average price of previous purchases. This resulted in an overall loss of USD 18,453 The average price that the ETF previously sold ISRG share for is USD 529.527 which is higher than the selling price of USD 512.23 on 2025-07-15. |
| MRK - Marks Electrical Group PLC | SELL | -5,584 @ USD 81.52 | USD -455,208 | The ETF sold 5584 shares of MRK on 2025-07-15. The shares were previously bought for an average price of USD 90.1354. The Marks Electrical Group PLC shares were sold for -9.6% lower than average price of previous purchases. This resulted in an overall loss of USD 48,108 The average price that the ETF previously sold MRK share for is USD 94.8861 which is higher than the selling price of USD 81.52 on 2025-07-15. |
| MRK - Merck & Company Inc | SELL | -5,584 @ USD 81.52 | USD -455,208 | The ETF sold 5584 shares of MRK on 2025-07-15. The shares were previously bought for an average price of USD 90.1354. The Merck & Company Inc shares were sold for -9.6% lower than average price of previous purchases. This resulted in an overall loss of USD 48,108 The average price that the ETF previously sold MRK share for is USD 94.8861 which is higher than the selling price of USD 81.52 on 2025-07-15. |
| ABT - Abbott Laboratories | SELL | -3,868 @ USD 131.49 | USD -508,603 | The ETF sold 3868 shares of ABT on 2025-07-15. The shares were previously bought for an average price of USD 128.101. The Abbott Laboratories shares were sold for 2.6% higher than average price of previous purchases. This sale made a profit of USD 13,109 The average price that the ETF previously sold ABT share for is USD 121.265 so the ETF has sold 3868 shares on 2025-07-15 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -2,012 @ USD 291.71 | USD -586,921 | The ETF sold 2012 shares of UNH on 2025-07-15. The shares were previously bought for an average price of USD 495.756. The UnitedHealth Group Incorporated shares were sold for -41.2% lower than average price of previous purchases. This resulted in an overall loss of USD 410,541 The average price that the ETF previously sold UNH share for is USD 499.833 which is higher than the selling price of USD 291.71 on 2025-07-15. |
| ABBV - AbbVie Inc | SELL | -3,912 @ USD 186.39 | USD -729,158 | The ETF sold 3912 shares of ABBV on 2025-07-15. The shares were previously bought for an average price of USD 192.168. The AbbVie Inc shares were sold for -3.0% lower than average price of previous purchases. This resulted in an overall loss of USD 22,604 The average price that the ETF previously sold ABBV share for is USD 185.621 so the ETF has sold 3912 shares on 2025-07-15 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -5,320 @ USD 155.17 | USD -825,504 | The ETF sold 5320 shares of JNJ on 2025-07-15. The shares were previously bought for an average price of USD 156.97. The Johnson & Johnson shares were sold for -1.1% lower than average price of previous purchases. This resulted in an overall loss of USD 9,576 The average price that the ETF previously sold JNJ share for is USD 152.91 so the ETF has sold 5320 shares on 2025-07-15 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -1,728 @ USD 771.75 | USD -1,333,584 | The ETF sold 1728 shares of LLY on 2025-07-15. The shares were previously bought for an average price of USD 829.133. The Eli Lilly and Company shares were sold for -6.9% lower than average price of previous purchases. This resulted in an overall loss of USD 99,158 The average price that the ETF previously sold LLY share for is USD 792.18 which is higher than the selling price of USD 771.75 on 2025-07-15. |